Export: +91 9820402906   Domestic: +91 7710003340 | HR: +91 9137757219
Chlorpromazine Hydrochloride Tablets

Chlorpromazine Hydrochloride Tablets

Healthy Life Pharma

Chlorpromazine Hydrochloride Tablets IP 25 mg
Each Sugar Coated Tablet Contains:
Chlorpromazine Hydrochloride IP 25 mg

Chlorpromazine Hydrochloride Tablets IP 50 mg
Each Sugar Coated Tablet Contains:
Chlorpromazine Hydrochloride IP 50 mg
Excipients q.s.

Chlorpromazine Tablets IP 100 mg
Each Sugar Coated Tablet Contains:
Chlorpromazine Hydrochloride IP 100 mg

Chlorpromazine Tablets IP 200 mg
Each Sugar Coated Tablet Contains:
Chlorpromazine Hydrochloride IP 200 mg
Excipients q.s.

Usage: Treatment of schizophrenia and other approved indications under medical supervision

Category: Anti Psychotic Drugs + CNS

Therapeutic Category: Typical Antipsychotic / Phenothiazine

SKU: Chlorpromazine Hydrochloride Tablets

Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations

Product Information

Chlorpromazine Hydrochloride Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.

For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.

Description

Chlorpromazine Hydrochloride Tablets (25mg / 50mg / 100mg / 200mg)

Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. is a specialized manufacturer of Chlorpromazine Hydrochloride Tablets in India. Chlorpromazine is a first-generation (typical) phenothiazine antipsychotic used for schizophrenia and certain other psychiatric or medical indications according to approved local prescribing information. Manufacturing controls include attention to low-light handling, product stability, containment and suitable coating and packaging systems.

2. Product Specifications

ParameterSpecification
Product NameChlorpromazine Hydrochloride Tablets
Generic NameChlorpromazine Hydrochloride Tablets USP / BP / IP
CAS Number69-09-0
Strength25mg / 50mg / 100mg / 200mg
Dosage FormSugar Coated / Film Coated Tablet, according to registered formulation
StandardUSP / BP / IP, as applicable
Therapeutic ClassTypical Antipsychotic (Phenothiazine) / Antiemetic
Shelf Life36 Months, subject to validated stability data
Packaging10×10 Blister / institutional pack or market-specific packaging

3. Manufacturing Technology

  • Light Protection: Chlorpromazine formulations require appropriate controls against light exposure. Coating and protective packaging are selected according to validated stability requirements.
  • Containment: Controlled handling and cleaning procedures help protect operators and reduce cross-contamination risk during manufacturing.
  • Coating: Sugar-coated or film-coated presentations can mask the bitter taste and provide additional product protection according to the registered formulation.
  • Institutional Packs: High-count packaging can be supported where permitted by stability data and destination-market registration.

4. Quality Assurance

  • Related Substances: Relevant degradation products, including oxidative impurities, are monitored according to approved specifications.
  • Dissolution: Finished tablets are tested against the applicable registered or pharmacopoeial dissolution requirements.
  • Assay & Uniformity: Potency and dosage-unit uniformity are verified against approved specifications.

5. Chlorpromazine Pharmacology and Uses

Chlorpromazine primarily antagonizes dopamine D2 receptors and also has activity at alpha-adrenergic, histamine and muscarinic receptors. These actions contribute both to its therapeutic effects and its adverse-effect profile.

  • Schizophrenia / Psychotic Disorders: Used to manage psychotic symptoms according to approved prescribing information.
  • Manic States: May be used in selected acute manic presentations where locally approved.
  • Nausea and Vomiting: Has antiemetic activity and may be used for selected indications.
  • Persistent Hiccups: Chlorpromazine has a recognized role in selected cases under medical supervision.
  • Other Uses: Additional indications differ by jurisdiction and should follow current registered labeling and clinical guidance.

6. Export and Regulatory Support

  • Dossier Support: CTD / ACTD documentation where applicable.
  • Certificates: FSC, COPP and COA where applicable.
  • Logistics: Air or sea shipment via FOB Mumbai / CIF according to destination-market requirements.

7. Frequently Asked Questions

Q: Who manufactures Chlorpromazine Hydrochloride Tablets?
A: Healthy Life Pharma Pvt. Ltd. manufactures Chlorpromazine tablet formulations in India.

Q: Is Chlorpromazine sold under different brand names?
A: Yes. It has been marketed under different brands internationally. Generic equivalence and interchangeability depend on the registered formulation and local regulatory requirements.

Q: Can Chlorpromazine cause tremor or stiffness?
A: Yes. Extrapyramidal symptoms such as tremor, rigidity, dystonia or akathisia can occur. These symptoms require clinical assessment rather than self-treatment.

Q: Does Chlorpromazine cause sun sensitivity?
A: Photosensitivity can occur. Patients should follow medical advice on limiting excessive sunlight and using appropriate sun protection.


Clinical Pharmacology & Safety Information

(For Registered Medical Practitioners & Patient Reference)

8. Dosage and Administration

  • Dose: Dosing varies substantially by indication, age, response, comorbidities and local approved prescribing information.
  • Titration: Treatment is generally individualized and adjusted according to clinical response and tolerability.
  • Administration: Follow the instructions supplied with the specific registered product. Patients should not alter the dose without medical guidance.

9. Side Effects and Precautions

  • CNS: Sedation, dizziness and impaired alertness can occur.
  • Extrapyramidal Effects: Dystonia, akathisia, parkinsonism and tardive dyskinesia can occur, particularly with ongoing exposure.
  • Cardiovascular: Orthostatic hypotension and tachycardia can occur; QT-related cardiac risk should also be considered where relevant.
  • Neuroleptic Malignant Syndrome: Fever, severe muscle rigidity, altered mental status or autonomic instability may indicate this rare medical emergency and require urgent treatment.
  • Photosensitivity: Increased sensitivity to sunlight and skin reactions can occur.
  • Other Important Risks: Anticholinergic effects, hepatic reactions and ocular changes can occur. Monitoring should follow clinical circumstances and prescribing information.

10. Storage Instructions

  • Store below 25°C in a dry place unless the registered label specifies otherwise.
  • Protect from light and moisture.
  • Keep tablets in their original protective packaging.
  • Do not use tablets showing unexpected discoloration or deterioration; consult the manufacturer/pharmacist regarding product quality.
  • Keep out of reach of children.